This inventor holds 1 USPTO granted patent. Top assignees: Ici Americas, Inc., Imperial Chemical Industries Limited. Active years: 1987.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
1 out of 432 
1 out of 3,840 
Years Active: 1987
Title: The Innovative Contributions of Karin M. Kirkland
Introduction
Karin M. Kirkland is a notable inventor based in Wilmington, DE (US). She has made significant contributions to the field of pharmaceuticals, particularly in the development of compounds that serve as histamine H-2 antagonists. Her work has implications for ulcer therapy, showcasing her impact on medical advancements.
Latest Patents
Kirkland holds a patent for "Guanidinopyrazolylamides, guanidimoimidazolylamides, compositions." This patent describes a guanidine derivative that includes a variety of radicals and is useful in pharmaceutical compositions. The compound is particularly noted for its application in ulcer therapy, highlighting its therapeutic potential.
Career Highlights
Throughout her career, Karin has worked with prominent companies such as Ici Americas, Inc. and Imperial Chemical Industries Limited. Her experience in these organizations has contributed to her expertise in pharmaceutical innovation and development.
Collaborations
Kirkland has collaborated with Derrick M. Mant, further enhancing her research and development efforts in the pharmaceutical field.
Conclusion
Karin M. Kirkland's contributions to pharmaceutical innovation, particularly through her patent on histamine H-2 antagonists, underscore her role as a significant inventor in the industry. Her work continues to influence therapeutic approaches in medicine.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile